2024
|
Invention
|
Package and method for producing the same.
There is provided a package wherein a pharmaceutical ... |
|
Invention
|
Composition comprising glycosaminoglycan derivative and chemokine receptor activity regulator.
P... |
|
Invention
|
Therapeutic agent for disc herniation.
The present invention provides a therapeutic agent for di... |
|
Invention
|
Administering device and medical implement. This administering device enables stable dispersion, ... |
2023
|
Invention
|
Recombinant factor c and method for producing the same, and method for measuring endotoxin. Carci... |
|
Invention
|
Pharmaceutical composition, package and method for producing the same. A pharmaceutical compositi... |
2022
|
Invention
|
Horseshoe crab factor b variant.
Provided is a technology related to a horseshoe crab factor B v... |
|
Invention
|
Reagent for measuring b-glucan, method for producing same and use thereof.
A reagent for β-gluca... |
|
Invention
|
Reagent for measuring β-glucan, method for producing same and use thereof. The present invention ... |
|
Invention
|
Syringe |
|
Invention
|
Stabilized aqueous composition comprising chondroitin sulfate and hyaluronic acid.
The present i... |
|
Invention
|
Therapeutic agent for disc herniation. The present invention provides a therapeutic agent for dis... |
|
Invention
|
Composition including glucosaminoglycan derivative and chemokine receptor activity regulator.
Pr... |
2021
|
Invention
|
Novel recombinant factor c and method for producing the same, and method for measuring endotoxin.... |
|
Invention
|
Composition for treating joint disease and kit containing same. The present invention pertains to... |
|
Invention
|
Agent for improving ocular subjective symptoms and method thereof. Provided is an agent for impro... |
|
Invention
|
Method for measuring endotoxin.
A method for rapidly and highly sensitively measuring endotoxin ... |
|
Invention
|
Agent to be used in intraocular membrane detachment surgery.
An object of the present invention ... |
|
Invention
|
Agent to be used in intraocular membrane detachment surgery. The present invention addresses the ... |
|
Invention
|
Agent to be used in intraocular membrane detachment surgery. maxmax (Pa/sec) stands for the maxim... |
2020
|
Invention
|
Transmucosal delivery system for pharmaceutical active ingredient to submucosal tissue of bladder... |
|
Invention
|
Transmucosal delivery system for medicinal active ingredient to submucosa of bladder. As a system... |
|
P/S
|
Instruments for detecting and measuring endotoxins; Instrument for scientific, medical research a... |
|
P/S
|
Laboratory instruments for the detection of pathogens and toxins in a biological sample for resea... |
|
Invention
|
Agent for improving ocular subjective symptoms and method thereof. Provided is an agent for provi... |
|
Invention
|
Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease... |
|
Invention
|
Method for improving storage stability.
A submucosal injection material whose quality deteriorat... |
|
Invention
|
Method for improving storage stability. The present invention provides a material for submucosal ... |
2019
|
Invention
|
Agent to be applied to ophthalmic device.
Provided is a preparation to be applied to an ophthalm... |
|
Invention
|
Glycosaminoglycan derivative and method for producing same.
The present invention provides a gly... |
|
Invention
|
Pharmaceutical composition containing a hyaluronic acid derivative. Provided is a method for supp... |
|
Invention
|
Pharmaceutical composition. The purpose of the present invention is to provide a pharmaceutical c... |
|
Invention
|
Pharmaceutical composition. 1323366 trialcohol, a polyalkylene glycol, γ-lactone, polyvinylpyrrol... |
|
Invention
|
Primary amine compound or secondary amine compound-acidic polysaccharide conjugate and production... |
|
Invention
|
Primary amine compound- or secondary amine compound-acidic polysaccharide conjugate, and method f... |
|
Invention
|
Method for enhancing sensitivity of endotoxin measuring agent.
An object of the present inventio... |
|
Invention
|
Method for enhancing sensitivity of endotoxin measuring agent. The present invention addresses th... |
|
Invention
|
Polymer conjugate bonded to tertiary amine compound or imine compound and production method there... |
|
Invention
|
Bioactive carboxylic acid type compound-polymer conjugate, and method for manufacturing the same.... |
|
Invention
|
Hyaluronic acid synthesis promoter, method for promoting hyaluronic acid synthesis, and cell eval... |
|
Invention
|
Package and method for producing the same. There is provided a package wherein a pharmaceutical c... |
|
Invention
|
Pharmaceutical composition, package and method for producing the same. There are provided a pharm... |
2018
|
Invention
|
Drug storage container, closing member, method for manufacture of drug storage container, method ... |
|
Invention
|
An agent, a device and a blood-circulation system for treating lysosomal storage diseases, and a ... |
|
Invention
|
Finger grip for syringe |
|
Invention
|
Tertiary amine compound or imine compound-polymer conjugate and production method therefor.
Prov... |
|
Invention
|
Composition for treating joint disease and kit containing same. 2 or higher. |
|
Invention
|
Horseshoe crab factor b variant. Limulus reagent by combining this polypeptide with horseshoe cra... |
2013
|
P/S
|
Pharmaceutical preparations in gel state for intra-articular
injection; therapeutic preparations... |
2009
|
P/S
|
(( [ Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of p... |
|
P/S
|
[ Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of phar... |
|
P/S
|
Hyaluronic acid; chondroitin sulfate; chemicals; reagents
for assay of endotoxin; reagents for a... |